These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2317948)

  • 1. The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody.
    Blank M; Sredni B; Albeck M; Mozes E; Shoenfeld Y
    Clin Exp Immunol; 1990 Mar; 79(3):443-7. PubMed ID: 2317948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels.
    Kalechman Y; Gafter U; Da JP; Albeck M; Alarcon-Segovia D; Sredni B
    J Immunol; 1997 Sep; 159(6):2658-67. PubMed ID: 9300685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
    Kalechman Y; Sredni B
    J Immunol; 1996 Jul; 157(2):589-97. PubMed ID: 8752906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the new immunoregulator AS-101 on in vitro functions of mononuclear cells from patients with systemic lupus erythematosus.
    Alcocer-Varela J; Alarcon-Segovia D; Sredni B; Albeck M
    Clin Exp Immunol; 1989 Sep; 77(3):319-23. PubMed ID: 2530012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent.
    Sredni B; Albeck M; Kazimirsky G; Shalit F
    Int J Immunopharmacol; 1992 May; 14(4):613-9. PubMed ID: 1521929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
    Kalechman Y; Rushkin G; Nerubay J; Albeck M; Sredni B
    Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculosis antibody TB/68 (16/6 Id+).
    Blank M; Mendlovic S; Mozes E; Coates AR; Shoenfeld Y
    Clin Immunol Immunopathol; 1991 Sep; 60(3):471-83. PubMed ID: 1830833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
    Kalechman Y; Gafter U; Gal R; Rushkin G; Yan D; Albeck M; Sredni B
    J Immunol; 2002 Jul; 169(1):384-92. PubMed ID: 12077268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
    Kalechman Y; Zuloff A; Albeck M; Strassmann G; Sredni B
    Blood; 1995 Mar; 85(6):1555-61. PubMed ID: 7888674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
    Kalechman Y; Shani A; Albeck M; Sredni B
    Immunopharmacology; 1995 Mar; 29(2):149-58. PubMed ID: 7539780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased DNA repair ability after irradiation following treatment with the immunomodulator AS101.
    Kalechman Y; Shani A; Albeck M; Sotnik Barkai I; Sredni B
    Radiat Res; 1993 Nov; 136(2):197-204. PubMed ID: 8248476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of experimental systemic lupus erythematosus with linomide.
    Zandman-Goddard G; George J; Levy Y; Blank M; Slavin S; Shoenfeld Y
    Lupus; 1996 Aug; 5(4):328-33. PubMed ID: 8869907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice.
    Rosenblatt-Bin H; Kalechman Y; Vonsover A; Xu RH; Da JP; Shalit F; Huberman M; Klein A; Strassmann G; Albeck M; Sredni B
    Cell Immunol; 1998 Feb; 184(1):12-25. PubMed ID: 9626331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats.
    Halpert G; Halperin Sheinfeld M; Monteran L; Sharif K; Volkov A; Nadler R; Schlesinger A; Barshak I; Kalechman Y; Blank M; Shoenfeld Y; Amital H
    Clin Exp Immunol; 2021 Mar; 203(3):375-384. PubMed ID: 33205391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations.
    Dayan M; Zinger H; Kalush F; Mor G; Amir-Zaltzman Y; Kohen F; Sthoeger Z; Mozes E
    Immunology; 1997 Jan; 90(1):101-8. PubMed ID: 9038719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory effects of AS101 on interleukin-2 production and T-lymphocyte function of lymphocytes treated with psoralens and ultraviolet A.
    Kozenitzky L; David M; Sredai B; Albeck M; Shohat B
    Photodermatol Photoimmunol Photomed; 1992 Feb; 9(1):24-8. PubMed ID: 1390119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.
    Kalechman Y; Gafter U; Weinstein T; Chagnac A; Freidkin I; Tobar A; Albeck M; Sredni B
    J Biol Chem; 2004 Jun; 279(23):24724-32. PubMed ID: 15001575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of early and late administration of M-20 derived interleukin-1 inhibitor on experimental systemic lupus erythematosus.
    Zandman-Goddard G; George J; Bland M; Levy Y; Yanai P; Halperin T; Shoenfeld Y; Barak V
    Immunol Lett; 1996 Nov; 53(2-3):77-82. PubMed ID: 9024982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
    Levite M; Zinger H; Mozes E; Reisner Y
    Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin.
    Sredni B; Kalechman Y; Albeck M; Gross O; Aurbach D; Sharon P; Sehgal SN; Gurwith MJ; Michlin H
    Immunology; 1990 Aug; 70(4):473-7. PubMed ID: 2118479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.